![Didier Cassereau](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Didier Cassereau first degree
Entity | Entity type | Industry | |
---|---|---|---|
BrainTale SAS
![]() BrainTale SAS Packaged SoftwareTechnology Services BrainTale SAS engages in the development and distribution of diagnosis and prognosis tools for brain injured patients. Its products include BrainQuant and BrainScore-coma. The company was founded by Vincent Perlbarg, Julie Rachline, Didier Cassereau, Louis Puybasset, Damien Galanaud, and Lionel Velly on July 6, 2018 and is headquartered in Paris, France.
7
| Holding Company | Packaged Software | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Didier Cassereau via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Anadys Pharmaceuticals, Inc.
![]() Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Founder | |
SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cellzome Ltd.
![]() Cellzome Ltd. Pharmaceuticals: MajorHealth Technology Cellzome Ltd. engages in the research, development, and manufacture of pharmaceutical products. It provides kinase-targeted drugs to treat inflammatory diseases. The company was founded by Gitte Neubauer on December 22, 2003 and is headquartered in Middlesex, the United Kingdom. | Pharmaceuticals: Major | Founder | |
Les Laboratoires Servier SAS
![]() Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Matignon Investissement et Gestion SAS
![]() Matignon Investissement et Gestion SAS Investment ManagersFinance Matignon Investissement et Gestion SAS (MIG) is an independent management-owned private equity investment firm based in Paris. MIG was established in 1996 through a management buy-out of Acmer from Banque Worms, formerly part of AXA-UAP and acquired by Deutsche Bank AG in 2001. Following the acquisition, Acmer was delisted. MIG manages private equity and venture capital funds, both generalist and sector specific. | Investment Managers | Private Equity Investor | |
Turenne Capital Partenaires SA
![]() Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital Partenaires SA (Turenne Capital) is a venture capital subsidiary of Turenne Associés SA founded in 1999 by Aymard de Lasteyrie. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor | |
University of Cambridge | College/University | Doctorate Degree | |
Kaneka Eurogentec SA
![]() Kaneka Eurogentec SA BiotechnologyHealth Technology Kaneka Eurogentec SA distributes reagents, kits and other related products for the biotechnology, pharmaceutical, and diagnostic sectors. It offers a range of services, from basic research in genomics and proteomics, to services associated with the development and manufacture of diagnostic and therapeutic products. The company was founded in 1985 and is headquartered in Seraing, Belgium. | Biotechnology | Director/Board Member | |
Swiss Federal Institute of Technology | College/University | Graduate Degree | |
École Normale Supérieure | College/University | Doctorate Degree | |
Massachusetts General Hospital Cancer Center
![]() Massachusetts General Hospital Cancer Center Hospital/Nursing ManagementHealth Services Massachusetts General Hospital Cancer Center operates as cancer treatment center. The company was founded by John Warren in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Fondation Santé | Founder | ||
European Molecular Biology Organization | Corporate Officer/Principal | ||
NANOBIOTIX | Medical Specialties | Director/Board Member | |
VOLUNTIS S.A. | Packaged Software | Director/Board Member | |
Harvard Medical School | College/University | Corporate Officer/Principal | |
Institut Curie
![]() Institut Curie Miscellaneous Commercial ServicesCommercial Services Institut Curie engages as a non-profit foundation. It operates a research center on biophysics, cell biology, and oncology and a hospital specialized in treatment of cancer. The company was founded in 1909 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
Stimulus SAS
![]() Stimulus SAS Miscellaneous Commercial ServicesCommercial Services Stimulus SAS is a holding company, which provides consulting services for management and health at work. It offers anti-stress tools to companies. The company was founded by Patrick Légeron in 1989 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
ADVICENNE | Pharmaceuticals: Generic | Investor Relations Contact | |
Cellzome, Inc.
![]() Cellzome, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Cellzome, Inc. develops immune-inflammation therapy. The company is based in Philadelphia, PA. The company was founded by Spyridon Artavanis-Tsakonas, Stelios Papadopoulos. | Pharmaceuticals: Major | Founder | |
GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Tissium SA
![]() Tissium SA BiotechnologyHealth Technology Tissium SA engages in the development and commercialization of biodegradable sealants and adhesives for invasive surgery. It offers biomimetic wound closure solutions. The company was founded by Bernard J. Gilly, Robert S. Langer, Christophe Bancel, Jeff Karp, Jacques Marescaux, Maria Pereira, and Patrick Houvet in 2013 and is headquartered in Paris, France. | Biotechnology | Corporate Officer/Principal | |
L3S Partnership | Corporate Officer/Principal | ||
Cambridge Philosophical Society
![]() Cambridge Philosophical Society Investment Trusts/Mutual FundsMiscellaneous The Cambridge Philosophical Society provides grant making services. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Academy of Athens | Corporate Officer/Principal | ||
ESCP Europe | College/University | Graduate Degree | |
Brainever SAS
![]() Brainever SAS Pharmaceuticals: MajorHealth Technology Brainever SAS manufactures pharmaceutical products. It develops medicines for nervous system diseases. The company was founded on March 31, 2015 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member Founder | |
NH THERAGUIX SAS | Pharmaceuticals: Major | Director/Board Member | |
Ntz Consulting SASU | Chairman |
Statistics
International
France | 19 |
United States | 7 |
United Kingdom | 4 |
Greece | 3 |
Germany | 3 |
Sectoral
Health Technology | 17 |
Consumer Services | 6 |
Finance | 3 |
Commercial Services | 3 |
Health Services | 2 |
Operational
Corporate Officer/Principal | 12 |
Founder | 11 |
Director/Board Member | 10 |
Private Equity Investor | 2 |
Doctorate Degree | 2 |
Most connected contacts
- Stock Market
- Insiders
- Didier Cassereau
- Company connections